机器学习在药物警戒中的应用:从氟嘧啶类毒性表型估计患者基因型
该研究开发自动机器学习模型,利用药物警戒数据库中氟嘧啶类毒性表型表现作为替代指标,估计双氢嘧啶脱氢酶(DPD)缺陷相关毒性病例数。结果显示8,878例(7.0%)至16,549例(13.1%)患者具有类似DPD缺陷状态的特征,但模型准确率约90%提示存在过拟合,需谨慎解读。
要点
- 药物警戒数据库仅含DPD缺陷的表型表现,缺乏基因型信息,难以估计DPD相关病例数。
- 自动机器学习模型以毒性表型模式为替代,估计7.0%至13.1%患者具有类似DPD缺陷特征。
- 模型准确率约90%提示可能过拟合,结果需谨慎解读,监管应用需进一步研究。
核心结论
- 机器学习可利用氟嘧啶类毒性表型表现作为替代指标估计DPD缺陷相关毒性病例数,但模型可能存在过拟合,结果需谨慎解读。
研究设计与样本
- 研究开发自动机器学习模型,训练氟嘧啶类毒性表型表现的模式,并以此作为替代估计DPD相关毒性病例数。
主要发现
- 估计有8,878例(7.0%)至16,549例(13.1%)患者具有类似DPD缺陷状态的特征。
- 变量重要性分析结果与已知的DPD相关毒性终末器官损伤相符。
- 模型准确率在90%范围内,提示存在过拟合。
关键数值与推荐
- 估计具有类似DPD缺陷状态特征的患者数为8,878例(7.0%)至16,549例(13.1%)。
- 模型准确率在90%范围内。
临床怎么用
- 该研究提示机器学习可在监管情境中用于药物警戒信号估计,但当前结果因过拟合风险需谨慎解读,尚不能直接用于临床决策。
局限性
- 模型准确率在90%范围内提示存在过拟合,结果需谨慎解读。
- 研究仅使用表型表现作为替代,缺乏基因型信息。
- 监管适用性仍需额外研究进一步理解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dihydropyrimidine dehydrogenase (DPD)-deficient patients might only become aware of their genotype after exposure to dihydropyrimidines, if testing is performed. Case reports to pharmacovigilance databases might only contain phenotypical manifestations of DPD, without information on the genotype. This poses a difficulty in estimating the cases due to DPD. Auto machine learning models were developed to train patterns of phenotypical manifestations of toxicity, which were then used as a surrogate to estimate the number of cases of DPD-related toxicity. Results indicate that between 8,878 (7.0%) and 16,549 (13.1%) patients have a profile similar to DPD deficient status. Results of the analysis of variable importance match the known end-organ damage of DPD-related toxicity, however, accuracies in the range of 90% suggest presence of overfitting, thus, results need to be interpreted carefully. This study shows the potential for use of machine learning in the regulatory context but additional studies are required to better understand regulatory applicability.
引用
- Correia Pinheiro L, Durand J, Dogné JM, et al. An Application of Machine Learning in Pharmacovigilance: Estimating Likely Patient Genotype From Phenotypical Manifestations of Fluoropyrimidine Toxicity. Clin Pharmacol Ther. 2020. PMID: 31955411. doi:10.1002/cpt.1789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。